Dr. Millard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Drive
Moores UCSD Cancer Center , MC 0987
La Jolla, CA 92093Phone+1 858-822-6185Fax+1 858-249-0905
Education & Training
- Naval Medical Center (San Diego)Fellowship, Hematology and Medical Oncology, 1984 - 1987
- Naval Medical Center (San Diego)Residency, Internal Medicine, 1982 - 1984
- Naval Medical Center (San Diego)Internship, Internal Medicine, 1980 - 1981
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1980
Certifications & Licensure
- CA State Medical License 1984 - 2026
- PA State Medical License 1990 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma Start of enrollment: 2003 Apr 01
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies Start of enrollment: 2009 Dec 11
- Join now to see all
Publications & Presentations
PubMed
- 81 citationsPhase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinomaMatthew I. Milowsky, Christian Dittrich, Ignacio Duran, Satinder Jagdev, Frederick Millard
European Journal of Cancer. 2014-12-01 - 8 citationsChange in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinomaZachary Hamilton, Hak J. Lee, Juan Jimenez, Brian R. Lane, Song Wang
BJU International. 2016-12-01 - 46 citationsNeoadjuvant therapy for localized and locally advanced renal cell carcinoma.Ahmet Bindayi, Zachary Hamilton, Michelle L. McDonald, Kendrick Yim, Frederick Millard
Urologic Oncology. 2018-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: